Literature DB >> 30838477

Spanish Validation of the Child Anxiety Life Interference Scale (CALIS-C): Psychometric Properties, Factorial Structure and Factorial Invariance Across Gender.

Mireia Orgilés1, Iván Fernández-Martínez2, Alexandra Morales1, Silvia Melero1, José P Espada1.   

Abstract

The Child Anxiety Life Interference Scale (CALIS-C) is a measure created to specifically identify life interference and impairment related to children's anxiety disorders in areas of daily functioning. Despite being a widely used scale, a Spanish version of the CALIS-C is not available. The purpose of this study was to adapt and validate the CALIS-C for Spanish-speaking children. We examined the CALIS-C factorial structure, factorial invariance across gender, and psychometric properties in a community sample of 336 (46.7% girls) Spanish-speaking children aged 8-12 years. Confirmatory factor analysis provided support for the original two-factor model. Excellent internal consistency coefficients were found for the total scale (0.88) and the subscales (0.85 and 0.82). 8-week test-retest reliability was moderate (IC = 0.51). Evidence of convergent and divergent validity was found, and factorial invariance across gender was reached. The current study provides initial support for the use of the CALIS-C with Spanish-speaking children by clinicians and researchers.

Entities:  

Keywords:  Anxiety disorders; Assessment; Child Anxiety Life Interference Scale; Children; Life interference

Mesh:

Year:  2019        PMID: 30838477     DOI: 10.1007/s10578-019-00879-4

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  21 in total

Review 1.  Comorbidity.

Authors:  A Angold; E J Costello; A Erkanli
Journal:  J Child Psychol Psychiatry       Date:  1999-01       Impact factor: 8.982

2.  Testing for multigroup equivalence of a measuring instrument: a walk through the process.

Authors:  Barbara M Byrne
Journal:  Psicothema       Date:  2008-11

3.  The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders.

Authors:  D S Pine; P Cohen; D Gurley; J Brook; Y Ma
Journal:  Arch Gen Psychiatry       Date:  1998-01

4.  Efficacy of a Danish version of the Cool Kids program: a randomized wait-list controlled trial.

Authors:  K Arendt; M Thastum; E Hougaard
Journal:  Acta Psychiatr Scand       Date:  2015-05-27       Impact factor: 6.392

5.  Prevalence and development of psychiatric disorders in childhood and adolescence.

Authors:  E Jane Costello; Sarah Mustillo; Alaattin Erkanli; Gordon Keeler; Adrian Angold
Journal:  Arch Gen Psychiatry       Date:  2003-08

6.  Children with co-occurring anxiety and externalizing disorders: family risks and implications for competence.

Authors:  Joan P Yoo; Pamela J Brown; Suniya S Luthar
Journal:  Am J Orthopsychiatry       Date:  2009-10

7.  Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood.

Authors:  Sabine J Roza; Marijke B Hofstra; Jan van der Ende; Frank C Verhulst
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

8.  The child anxiety impact scale: examining parent- and child-reported impairment in child anxiety disorders.

Authors:  Audra K Langley; Avital Falk; Tara Peris; Joshua F Wiley; Philip C Kendall; Golda Ginsburg; Boris Birmaher; John March; Ann Marie Albano; John Piacentini
Journal:  J Clin Child Adolesc Psychol       Date:  2013-08-05

Review 9.  Anxiety disorders during childhood and adolescence: origins and treatment.

Authors:  Ronald M Rapee; Carolyn A Schniering; Jennifer L Hudson
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

10.  Anxiety disorder symptoms in children and adolescents: differences by age and gender in a community sample.

Authors:  Mireia Orgilés; Xavier Méndez; José Pedro Espada; Jose Luis Carballo; José Antonio Piqueras
Journal:  Rev Psiquiatr Salud Ment       Date:  2012-03-20       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.